CA2437043C - Ligand detection method - Google Patents
Ligand detection method Download PDFInfo
- Publication number
- CA2437043C CA2437043C CA2437043A CA2437043A CA2437043C CA 2437043 C CA2437043 C CA 2437043C CA 2437043 A CA2437043 A CA 2437043A CA 2437043 A CA2437043 A CA 2437043A CA 2437043 C CA2437043 C CA 2437043C
- Authority
- CA
- Canada
- Prior art keywords
- nucleic acid
- sample
- receptors
- binding
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003446 ligand Substances 0.000 title claims abstract description 56
- 238000001514 detection method Methods 0.000 title description 48
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 87
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 84
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 84
- 238000009739 binding Methods 0.000 claims abstract description 63
- 230000027455 binding Effects 0.000 claims abstract description 61
- 238000000034 method Methods 0.000 claims abstract description 57
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 57
- 230000003321 amplification Effects 0.000 claims abstract description 52
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 45
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 32
- 229960002685 biotin Drugs 0.000 claims description 18
- 239000011616 biotin Substances 0.000 claims description 18
- 108020004414 DNA Proteins 0.000 claims description 17
- 235000020958 biotin Nutrition 0.000 claims description 16
- 108010090804 Streptavidin Proteins 0.000 claims description 14
- 229920002307 Dextran Polymers 0.000 claims description 11
- 102000053602 DNA Human genes 0.000 claims description 9
- 108090001008 Avidin Proteins 0.000 claims description 8
- 238000011901 isothermal amplification Methods 0.000 claims description 7
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 5
- 229920002521 macromolecule Polymers 0.000 claims description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 238000011895 specific detection Methods 0.000 abstract description 2
- 108020003175 receptors Proteins 0.000 description 66
- 102000005962 receptors Human genes 0.000 description 66
- 239000000523 sample Substances 0.000 description 37
- 239000002953 phosphate buffered saline Substances 0.000 description 20
- 239000000427 antigen Substances 0.000 description 19
- 102000036639 antigens Human genes 0.000 description 19
- 108091007433 antigens Proteins 0.000 description 19
- 239000003550 marker Substances 0.000 description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 238000012360 testing method Methods 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 12
- 238000007792 addition Methods 0.000 description 11
- 238000005406 washing Methods 0.000 description 11
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 7
- 239000012139 lysis buffer Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 230000001900 immune effect Effects 0.000 description 6
- 238000011065 in-situ storage Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000011897 real-time detection Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- -1 for example Chemical class 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 238000003118 sandwich ELISA Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- XVBRCOKDZVQYAY-UHFFFAOYSA-N bronidox Chemical compound [O-][N+](=O)C1(Br)COCOC1 XVBRCOKDZVQYAY-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000013024 dilution buffer Substances 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010249 in-situ analysis Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 238000000670 ligand binding assay Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000001525 receptor binding assay Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0029617.8 | 2000-12-05 | ||
| GBGB0029617.8A GB0029617D0 (en) | 2000-12-05 | 2000-12-05 | Ligand detection method |
| PCT/GB2001/005388 WO2002046464A2 (en) | 2000-12-05 | 2001-12-05 | Ligand detection method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2437043A1 CA2437043A1 (en) | 2002-06-13 |
| CA2437043C true CA2437043C (en) | 2011-10-11 |
Family
ID=9904463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2437043A Expired - Fee Related CA2437043C (en) | 2000-12-05 | 2001-12-05 | Ligand detection method |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7910294B2 (https=) |
| EP (1) | EP1364057B1 (https=) |
| JP (1) | JP4266634B2 (https=) |
| AR (1) | AR031631A1 (https=) |
| AT (1) | ATE429510T1 (https=) |
| AU (1) | AU2002220898A1 (https=) |
| CA (1) | CA2437043C (https=) |
| CY (1) | CY1109246T1 (https=) |
| DE (1) | DE60138486D1 (https=) |
| DK (1) | DK1364057T3 (https=) |
| ES (1) | ES2324462T3 (https=) |
| GB (2) | GB0029617D0 (https=) |
| PT (1) | PT1364057E (https=) |
| WO (1) | WO2002046464A2 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10011529T1 (de) | 1998-05-01 | 2011-09-01 | Gen-Probe Incorporated | Automatisches Diagnoseanalysegerät und Verfahren |
| US8337753B2 (en) | 1998-05-01 | 2012-12-25 | Gen-Probe Incorporated | Temperature-controlled incubator having a receptacle mixing mechanism |
| EP1602733A1 (en) * | 2004-06-02 | 2005-12-07 | Keygene N.V. | Detection of target nucleotide sequences using an asymmetric oligonucleotide ligation assay |
| WO2005021794A2 (en) | 2003-09-02 | 2005-03-10 | Keygene N.V. | Ola-based methods for the detection of target nucleic acid sequences |
| US20050214805A1 (en) * | 2003-11-10 | 2005-09-29 | Q-Rna, Inc. | Methods of detection employing immuno-Q-Amp technology |
| US20060199194A1 (en) * | 2003-11-10 | 2006-09-07 | Q-Rna, Inc. | Methods of detection using immuno-Q-Amp technology |
| JP4949038B2 (ja) * | 2003-12-01 | 2012-06-06 | ダコ デンマーク アクティーゼルスカブ | 免疫組織化学的検出のための方法および組成物 |
| US7964413B2 (en) | 2005-03-10 | 2011-06-21 | Gen-Probe Incorporated | Method for continuous mode processing of multiple reaction receptacles in a real-time amplification assay |
| EP2348320B1 (en) * | 2005-03-10 | 2024-05-01 | Gen-Probe Incorporated | Methods and systems for detecting multiple fluorescent emission signals |
| DE102008062372B3 (de) * | 2008-12-17 | 2010-06-17 | Medizinische Hochschule Hannover | Nachweiskonjugat und Verfahren zur Analyse |
| KR20130029128A (ko) | 2010-07-23 | 2013-03-21 | 베크만 컬터, 인코포레이티드 | 실시간 pcr용 용기 |
| US9046507B2 (en) | 2010-07-29 | 2015-06-02 | Gen-Probe Incorporated | Method, system and apparatus for incorporating capacitive proximity sensing in an automated fluid transfer procedure |
| EP2678664B1 (en) | 2011-02-24 | 2019-08-07 | Gen-Probe Incorporated | Systems and methods for distinguishing optical signals of different modulation frequencies in an optical signal detector |
| BR112014011044A2 (pt) | 2011-11-07 | 2017-04-25 | Beckman Coulter Inc | amortecimento magnético para sistema de transporte de espécime |
| JP6062449B2 (ja) | 2011-11-07 | 2017-01-18 | ベックマン コールター， インコーポレイテッド | 標本コンテナ検出 |
| KR20140092375A (ko) | 2011-11-07 | 2014-07-23 | 베크만 컬터, 인코포레이티드 | 원심분리기 시스템 및 작업 흐름 |
| BR112014010955A2 (pt) | 2011-11-07 | 2017-06-06 | Beckman Coulter Inc | sistema e método para processar amostras |
| EP2776846B1 (en) | 2011-11-07 | 2019-08-21 | Beckman Coulter, Inc. | Aliquotter system and workflow |
| KR102040996B1 (ko) | 2011-11-07 | 2019-11-05 | 베크만 컬터, 인코포레이티드 | 로봇식 아암 |
| US20140322706A1 (en) | 2012-10-24 | 2014-10-30 | Jon Faiz Kayyem | Integrated multipelx target analysis |
| JP1628115S (https=) | 2012-10-24 | 2019-04-01 | ||
| JP6351703B2 (ja) | 2013-03-15 | 2018-07-04 | アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ | 垂直配置カルーセルを有する自動診断分析装置および関連方法 |
| CN107866286A (zh) | 2013-03-15 | 2018-04-03 | 金马克诊断股份有限公司 | 用于操纵可变形流体容器的系统、方法和设备 |
| ES2970108T3 (es) | 2013-03-15 | 2024-05-27 | Abbott Lab | Analizadores de diagnóstico con carruseles de pretratamiento y métodos relacionados |
| WO2014144627A1 (en) | 2013-03-15 | 2014-09-18 | Abbott Laboratories | Automated diagnostic analyzers having rear accessible track systems and related methods |
| USD881409S1 (en) | 2013-10-24 | 2020-04-14 | Genmark Diagnostics, Inc. | Biochip cartridge |
| US9498778B2 (en) | 2014-11-11 | 2016-11-22 | Genmark Diagnostics, Inc. | Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system |
| US10005080B2 (en) | 2014-11-11 | 2018-06-26 | Genmark Diagnostics, Inc. | Instrument and cartridge for performing assays in a closed sample preparation and reaction system employing electrowetting fluid manipulation |
| US9598722B2 (en) | 2014-11-11 | 2017-03-21 | Genmark Diagnostics, Inc. | Cartridge for performing assays in a closed sample preparation and reaction system |
| CN106932590A (zh) * | 2015-12-31 | 2017-07-07 | 复旦大学 | 一种定量检测低丰度蛋白及其后修饰蛋白的方法 |
| US10427162B2 (en) | 2016-12-21 | 2019-10-01 | Quandx Inc. | Systems and methods for molecular diagnostics |
| US10871485B2 (en) | 2018-04-13 | 2020-12-22 | Rarecyte, Inc. | Kits for labeling of biomarkers and methods of using the same |
| US20230138285A1 (en) * | 2021-11-04 | 2023-05-04 | Miltenyi Biotec B.V. & Co. KG | Bright and releasable labels for cell staining based on the conjugates with several sites of fluorophore release |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656731A (en) * | 1987-10-15 | 1997-08-12 | Chiron Corporation | Nucleic acid-amplified immunoassay probes |
| US6083689A (en) * | 1990-10-16 | 2000-07-04 | Bayer Corporation | Sensitive immunoassays utilizing antibody conjugates with replicable DNA templates |
| EP0594772B1 (en) * | 1991-07-04 | 1996-08-28 | Immunodex K/S | Water-soluble, polymer-based reagents and conjugates comprising moieties derived from divinyl sulfone |
| US5665539A (en) * | 1991-07-12 | 1997-09-09 | The Regents Of The University Of California | Immuno-polymerase chain reaction system for antigen detection |
| AU6913394A (en) | 1993-05-13 | 1994-12-12 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nucleic acid tagged immunoassay |
| AU7839594A (en) * | 1993-09-20 | 1995-04-10 | Regents Of The University Of Colorado, The | Strategy for the production of rna from immobilized templates |
| WO1995030139A1 (en) * | 1994-04-29 | 1995-11-09 | Perkin-Elmer Corporation | System for real time detection of nucleic acid amplification products |
| US5854033A (en) * | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| DE69734576T2 (de) * | 1996-03-01 | 2006-08-03 | E.I. Dupont De Nemours And Co., Wilmington | Methode zur vervielfältigung und zum nachweis eines gewünschten nukleinsäurefragments |
| US6117631A (en) * | 1996-10-29 | 2000-09-12 | Polyprobe, Inc. | Detection of antigens via oligonucleotide antibody conjugates |
| WO1998020148A1 (en) * | 1996-11-04 | 1998-05-14 | The Regents Of The University Of California | Method for detection of pathogens in food |
| US6255060B1 (en) * | 1996-11-21 | 2001-07-03 | Trustees Of The University Of Pennsylvania | Method of detecting protein by immuno RNA |
| US5922553A (en) * | 1996-11-21 | 1999-07-13 | Trustees Of The University Of Pennsylvania | Method of detecting protein by immuno RNA |
| AT407160B (de) * | 1998-06-04 | 2001-01-25 | Immuno Ag | Verfahren zur bestimmung von antigenen |
| DE19915141C2 (de) * | 1999-03-26 | 2002-11-21 | Artus Ges Fuer Molekularbiolog | Detektion von Nucleinsäure-Amplifikaten |
| WO2001031056A2 (fr) * | 1999-10-27 | 2001-05-03 | Universite De Liege | Methode de detection par pcr |
-
2000
- 2000-12-05 GB GBGB0029617.8A patent/GB0029617D0/en not_active Ceased
-
2001
- 2001-12-05 DK DK01999671T patent/DK1364057T3/da active
- 2001-12-05 ES ES01999671T patent/ES2324462T3/es not_active Expired - Lifetime
- 2001-12-05 EP EP01999671A patent/EP1364057B1/en not_active Expired - Lifetime
- 2001-12-05 AT AT01999671T patent/ATE429510T1/de active
- 2001-12-05 DE DE60138486T patent/DE60138486D1/de not_active Expired - Lifetime
- 2001-12-05 PT PT01999671T patent/PT1364057E/pt unknown
- 2001-12-05 AR ARP010105648A patent/AR031631A1/es active IP Right Grant
- 2001-12-05 JP JP2002548181A patent/JP4266634B2/ja not_active Expired - Fee Related
- 2001-12-05 AU AU2002220898A patent/AU2002220898A1/en not_active Abandoned
- 2001-12-05 CA CA2437043A patent/CA2437043C/en not_active Expired - Fee Related
- 2001-12-05 US US10/433,548 patent/US7910294B2/en not_active Expired - Fee Related
- 2001-12-05 WO PCT/GB2001/005388 patent/WO2002046464A2/en not_active Ceased
- 2001-12-05 GB GB0129143A patent/GB2375822B/en not_active Expired - Fee Related
-
2009
- 2009-07-17 CY CY20091100763T patent/CY1109246T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2324462T3 (es) | 2009-08-07 |
| CY1109246T1 (el) | 2014-07-02 |
| WO2002046464A3 (en) | 2003-09-12 |
| AU2002220898A1 (en) | 2002-06-18 |
| GB0129143D0 (en) | 2002-01-23 |
| PT1364057E (pt) | 2009-07-06 |
| GB0029617D0 (en) | 2001-01-17 |
| CA2437043A1 (en) | 2002-06-13 |
| WO2002046464A2 (en) | 2002-06-13 |
| GB2375822B (en) | 2005-04-06 |
| EP1364057B1 (en) | 2009-04-22 |
| GB2375822A (en) | 2002-11-27 |
| EP1364057A2 (en) | 2003-11-26 |
| AR031631A1 (es) | 2003-09-24 |
| US7910294B2 (en) | 2011-03-22 |
| JP4266634B2 (ja) | 2009-05-20 |
| US20040076983A1 (en) | 2004-04-22 |
| DE60138486D1 (de) | 2009-06-04 |
| JP2004520574A (ja) | 2004-07-08 |
| ATE429510T1 (de) | 2009-05-15 |
| DK1364057T3 (da) | 2009-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2437043C (en) | Ligand detection method | |
| US6511809B2 (en) | Method for the detection of an analyte by means of a nucleic acid reporter | |
| EP2369015B1 (en) | Assay for localised detection of analytes | |
| US12540355B1 (en) | Nucleic acid reporter molecules for massively parallel DNA sequencing | |
| CN101988920A (zh) | 抗原检测试剂盒和方法 | |
| JP7815132B2 (ja) | 存在量が異なる分析物を検出するための方法 | |
| McKie et al. | Development of a quantitative immuno-PCR assay and its use to detect mumps-specific IgG in serum | |
| JPH05149949A (ja) | 新規な微量物質測定法 | |
| EP2189539B2 (en) | Conjugate complexes for analyte detection | |
| US5871906A (en) | Method for detection of amplified nucleic acid products and related diagnostic assays | |
| EP1879030B1 (en) | Use of a virus expressing a binding moiety to measure analytes in a sample | |
| JP2001013139A (ja) | 免疫学的測定法 | |
| WO1989009281A1 (en) | Method for amplifying and detecting nucleic acid in a test liquid | |
| US20260086090A1 (en) | Ultra-sensitive analyte detection and quantification using catch and release with proximity detection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20121205 |